Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Xtandi/Zytiga Combo Study Fails In Patients Previously Treated With Xtandi

Dec 15 2016

Related Content

Medivation/Astellas’ <em>Xtandi</em> A Tough Rival For J&J’s <em>Zytiga</em>

Sep 10 2012

With Medivation, Pfizer Sees A Chance For More Combinations

Aug 22 2016

Pfizer’s $14bn Medivation Buyout Shows How Far Pharma Will Go In Oncology

Aug 22 2016

Related Companies

Pfizer Inc.

Astellas Pharma, Inc.

Johnson & Johnson

Medivation, Inc.

Sanofi

Additional Topics

Research & Development Clinical Trials Cancer BioPharmaceutical

More from R&D

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window